Pharmacokinetic evaluation of pregabalin for the treatment of generalized anxiety disorder

Pregabalin for generalized anxiety disorder

(2017) Marcelo B. Generoso et al.   INTERNATIONAL CLINICAL PSYCHOPHARMACOLOGY

Attitudes toward utility, effects and side effects of treatment for anxiety and depression

(2016) Leslie Lim et al.   Australasian Psychiatry

Pregabalin for the Treatment of Drug and Alcohol Withdrawal Symptoms: A Comprehensive Review

(2016) Rainer Freynhagen et al.   CNS DRUGS

The Pharmacokinetics of Pregabalin in Breast Milk, Plasma, and Urine of Healthy Postpartum Women

(2016) Peter A. Lockwood et al.   JOURNAL OF HUMAN LACTATION

Pregnancy outcome following maternal exposure to pregabalin may call for concern

(2016) Ursula Winterfeld et al.   NEUROLOGY

Use of Pregabalin – A Nationwide Pharmacoepidemiological Drug Utilization Study with Focus on Abuse Potential

(2016) O. Schjerning et al.   PHARMACOPSYCHIATRY

Quetiapine monotherapy in acute treatment of generalized anxiety disorder: a systematic review and meta-analysis of randomized controlled trials

(2016) Narong Maneeton et al.   Drug Design Development and Therapy

Patología dual en trastornos de ansiedad: recomendaciones en el tratamiento farmacológico

(2016) Pilar Alejandra Sáiz Martínez et al.   Adicciones

Effect of the Gastrointestinal Prokinetic Agent Erythromycin on the Pharmacokinetics of Pregabalin Controlled-Release in Healthy Individuals: A Phase I, Randomized Crossover Trial

(2015) Marci L. Chew et al.   CLINICAL DRUG INVESTIGATION

Troubles anxieux résistants : revue des stratégies de traitements médicamenteux

(2015) G. Ammar et al.   ENCEPHALE-REVUE DE PSYCHIATRIE CLINIQUE BIOLOGIQUE ET THERAPEUTIQUE

Cosmetic side effects of antiepileptic drugs in adults with epilepsy

(2015) B. Chen et al.   EPILEPSY & BEHAVIOR

Pharmacokinetic evaluation of fluvoxamine for the treatment of anxiety disorders

(2015) Alfredo Carlo Altamura et al.   Expert Opinion on Drug Metabolism & Toxicology

Pharmacological treatment for generalized anxiety disorder in adults: an update

(2015) Jennifer A Reinhold et al.   EXPERT OPINION ON PHARMACOTHERAPY

Efficacy and safety of pregabalin in generalised anxiety disorder: A critical review of the literature

(2015) David S Baldwin et al.   JOURNAL OF PSYCHOPHARMACOLOGY

Rates and predictors of patient-reported cognitive side effects of antiepileptic drugs: An extended follow-up

(2015) Asif Javed et al.   SEIZURE-EUROPEAN JOURNAL OF EPILEPSY

Experience from therapeutic drug monitoring and gender aspects of gabapentin and pregabalin in clinical practice

(2015) Cecilie Johannessen Landmark et al.   SEIZURE-EUROPEAN JOURNAL OF EPILEPSY

Clinical and economic outcomes of adjunctive therapy with pregabalin or usual care in generalized anxiety disorder patients with partial response to selective serotonin reuptake inhibitors

(2015) Enrique Álvarez et al.   Annals of General Psychiatry

Long-Term Efficacy of OROS® Hydromorphone Combined with Pregabalin for Chronic Non-Cancer Neuropathic Pain

(2014) Mario Dauri et al.   CLINICAL DRUG INVESTIGATION

Pharmacokinetics of Pregabalin Controlled-Release in Healthy Volunteers: Effect of Food in Five Single-Dose, Randomized, Clinical Pharmacology Studies

(2014) Marci L. Chew et al.   CLINICAL DRUG INVESTIGATION

Pregabalin: A Review of its Use in Adults with Generalized Anxiety Disorder

(2014) James E. Frampton   CNS DRUGS

Safety, tolerability, and pharmacokinetics of pregabalin in children with refractory partial seizures: A phase 1, randomized controlled study

(2014) Donald Mann et al.   EPILEPSIA

Comparative safety and tolerability of duloxetine vs. pregabalin vs. duloxetine plus gabapentin in patients with diabetic peripheral neuropathic pain

(2014) G. Irving et al.   INTERNATIONAL JOURNAL OF CLINICAL PRACTICE

Effectiveness and Safety of Tapentadol Prolonged Release (PR) Versus a Combination of Tapentadol PR and Pregabalin for the Management of Severe, Chronic Low Back Pain With a Neuropathic Component: A Randomized, Double-blind, Phase 3b Study

(2014) Ralf Baron et al.   Pain Practice

Clinical Pharmacokinetics of New-Generation Antiepileptic Drugs at the Extremes of Age: An Update

(2013) Domenico Italiano et al.   CLINICAL PHARMACOKINETICS

Long-term treatment of anxiety disorders with pregabalin: a 1 year open-label study of safety and tolerability

(2013) Stuart Montgomery et al.   CURRENT MEDICAL RESEARCH AND OPINION

Efficacy and safety of pregabalin in patients with spinal cord injury: a pooled analysis

(2013) Bruce Parsons et al.   CURRENT MEDICAL RESEARCH AND OPINION

The Potential of Pregabalin in Neurology, Psychiatry and Addiction: A Qualitative Overview

(2013) Giovanni Martinotti et al.   CURRENT PHARMACEUTICAL DESIGN

Differences in latency to first pharmacological treatment (duration of untreated illness) in anxiety disorders: a study on patients with panic disorder, generalized anxiety disorder and obsessive-compulsive disorder

(2013) Bernardo Dell'Osso et al.   Early Intervention in Psychiatry

New approaches to the pharmacological management of generalized anxiety disorder

(2013) Massimiliano Buoli et al.   EXPERT OPINION ON PHARMACOTHERAPY

Pregabalin long-term treatment and assessment of discontinuation in patients with generalized anxiety disorder

(2013) Siegfried Kasper et al.   INTERNATIONAL JOURNAL OF NEUROPSYCHOPHARMACOLOGY

Concerns About Pregabalin

(2013) Maximilian Gahr et al.   Journal of Addiction Medicine

Levetiracetam and pregabalin for antiepileptic monotherapy in patients with primary brain tumors. A phase II randomized study

(2013) A. O. Rossetti et al.   NEURO-ONCOLOGY

Detection Times of Pregabalin in Urine After Illicit Use

(2013) Olav Spigset et al.   THERAPEUTIC DRUG MONITORING

A Comprehensive Drug Safety Evaluation of Pregabalin in Peripheral Neuropathic Pain

(2013) Rainer Freynhagen et al.   Pain Practice

Pregabalin for Alcohol Dependence: A Critical Review of the Literature

(2012) Riccardo Guglielmo et al.   ADVANCES IN THERAPY

Gabapentin to Pregabalin Therapy Transition

(2012) Howard N. Bockbrader et al.   AMERICAN JOURNAL OF THERAPEUTICS

Tolerability and use in co-administration of pregabalin in affective patients: a 6-month prospective naturalistic study

(2012) Cristina Dobrea et al.   Expert Opinion On Drug Safety

Adjunctive therapy with pregabalin in generalized anxiety disorder patients with partial response to SSRI or SNRI treatment

(2012) Karl Rickels et al.   INTERNATIONAL CLINICAL PSYCHOPHARMACOLOGY

Pregabalin augmentation of antidepressants in older patients with comorbid depression and generalized anxiety disorder-an open-label study

(2012) Dimitrios Karaiskos et al.   INTERNATIONAL JOURNAL OF GERIATRIC PSYCHIATRY

Guidelines for the pharmacological treatment of anxiety disorders, obsessive–compulsive disorder and posttraumatic stress disorder in primary care

(2012) Borwin Bandelow et al.   INTERNATIONAL JOURNAL OF PSYCHIATRY IN CLINICAL PRACTICE

Pregabalin-associated Elevation of Clozapine Serum Levels

(2012) M. Gahr et al.   PHARMACOPSYCHIATRY

Population pharmacokinetics of pregabalin in healthy subjects and patients with post-herpetic neuralgia or diabetic peripheral neuropathy

(2011) Satoshi Shoji et al.   BRITISH JOURNAL OF CLINICAL PHARMACOLOGY

Augmentative quetiapine in partial/nonresponders with generalized anxiety disorder

(2011) Alfredo Carlo Altamura et al.   INTERNATIONAL CLINICAL PSYCHOPHARMACOLOGY

Switching from long-term benzodiazepine therapy to pregabalin in patients with generalized anxiety disorder: a double-blind, placebo-controlled trial

(2011) Sallie J Hadley et al.   JOURNAL OF PSYCHOPHARMACOLOGY

Subjective, psychomotor, and physiological effects of pregabalin alone and in combination with oxycodone in healthy volunteers

(2011) James P. Zacny et al.   PHARMACOLOGY BIOCHEMISTRY AND BEHAVIOR

Pregabalin: Dose-Response Relationship in Generalized Anxiety Disorder

(2011) M. Boschen   PHARMACOPSYCHIATRY

An international survey of reported prescribing practice in the treatment of patients with generalised anxiety disorder

(2011) David S. Baldwin et al.   WORLD JOURNAL OF BIOLOGICAL PSYCHIATRY

Clinical Pharmacokinetics of Pregabalin in Healthy Volunteers

(2010) Howard N. Bockbrader et al.   JOURNAL OF CLINICAL PHARMACOLOGY

Long-term efficacy of pregabalin in generalized anxiety disorder

(2009) Douglas Feltner et al.   INTERNATIONAL CLINICAL PSYCHOPHARMACOLOGY

Efficacy of pregabalin and venlafaxine-XR in generalized anxiety disorder: results of a double-blind, placebo-controlled 8-week trial

(2009) Siegfried Kasper et al.   INTERNATIONAL CLINICAL PSYCHOPHARMACOLOGY

Does Pregabalin Have Neuropsychotropic Effects?: A Short Perspective

(2009) David M. Marks et al.   Psychiatry Investigation

Rash Associated with Pregabalin Use

(2008) Timothy L Smith et al.   ANNALS OF PHARMACOTHERAPY

Efficacy, Safety, and Tolerability of Pregabalin Treatment for Painful Diabetic Peripheral Neuropathy: Findings from seven randomized, controlled trials across a range of doses

(2008) R. Freeman et al.   DIABETES CARE

Efficacy and tolerability of pregabalin in patients with difficult-to-treat epilepsy and intellectual disability

(2008) Bernd Huber et al.   EPILEPSY & BEHAVIOR

Adjunctive pregabalin therapy in mentally retarded, developmentally delayed patients with epilepsy

(2008) Pradeep N. Modur et al.   EPILEPSY & BEHAVIOR

Human and economic burden of generalized anxiety disorder

(2006) Deborah L. Hoffman et al.   DEPRESSION AND ANXIETY